Author: Daniel snow

A variety of school supplies, including lunch boxes and backpacks in different colors and patterns, are on display for the upcoming school year.Deb Cohn-Orbach | UCG | Universal Images Group | Getty ImagesAlthough inflation is cooling, President Donald Trump’s new tariff rates are threatening to drive prices higher, which could leave some parents in a bind amid the back-to-school shopping season.Families are now paying more for some key back-to-school essentials, such as backpacks, ahead of the new school year. CNBC used the producer price index — a closely followed measure of inflation — to track how the costs of making certain items that…

Read More

Office of Management and Budget Director Russell Vought vowed Friday to press an investigation into renovations at the Federal Reserve building, which he called a “palace” where costs are running amok.In a potential escalation of President Donald Trump’s feud with Fed Chair Jerome Powell, Vought told CNBC that an investigation is warranted into whether Powell has been misleading about the $2.5 billion project.”When you go to the nation’s mall, you see the construction of this palace … , upwards of $2.5 billion massive cost overrun, and we want to make sure we have facts as to the largesse and the…

Read More

My top 10 things to watch Friday, July 11 1. Wall Street was set to open lower Friday, retreating from Thursday’s record-high closes for the S & P 500 and Nasdaq . Friday’s drop follows President Donald Trump announcing more tariffs. This time it’s 35% levies on Canada, starting on Aug. 1. 2. The tariffs on Canada are illusory because most of the trade is still protected. I think it is retaliation for the tech tariff that was repealed, and because Trump senses the stock market likes tariffs. I will address this in my speech this morning at the annual…

Read More

The Food and Drug Administration will consider drug affordability when granting companies new vouchers that speed up approvals of some treatments, the agency’s Commissioner Marty Makary told CNBC on Friday. The FDA in June announced a national priority voucher plan that aims to cut drug review times to one-to-two months for companies it says are supporting “U.S. national interests.” But previous announcements on the voucher program did not explicitly mention making drugs more affordable as a criterion. “We are including the affordability of drugs as a national priority,” Makary told CNBC.Lowering drug prices is a key goal of the Trump administration, which…

Read More